Early Detection of Genetic Disorders
With EG NIPT PRO, you can screen for potential genetic conditions early in your pregnancy.
Non-Invasive Prenatal Testing (NIPT) plays a crucial role in improving public health and
prenatal care. This allows you to be better informed and prepared, ensuring the best possible care for you and your baby.
The key benefits include:
By identifying genetic disorders early, expectant parents can make informed decisions about their pregnancy management.
EG NIPT PRO is a safer alternative to invasive procedures like amniocentesis, significantly minimizing risks to both mother and fetus.
Reducing the incidence of undiagnosed genetic disorders helps lower healthcare costs and improves population health outcomes.
Early diagnosis and intervention can enhance the quality of life for affected individuals and reduce the strain on families and healthcare systems.
It’s important to note that EG NIPT PRO is a screening test, which assesses the risk of certain conditions rather than providing a definitive diagnosis. Positive results should be followed up with diagnostic testing for confirmation.
EG NIPT PRO introduces cutting-edge NIPT services by leveraging third-generation sequencing. This advanced technology allows for more comprehensive genetic screening, providing superior accuracy and a broader detection range.
Risk Assessment
With EG NIPT PRO, the likelihood of identifying at least one genetic disorder is approximately 1 in 58 pregnancies, with a 1.73% risk factor.
This makes it an essential tool in understanding your baby’s genetic
health.
EG NIPT PRO detects abnormalities in chromosome numbers, identifying conditions like
This test also analyzes structural variations across the entire genome, providing deep insights into various genetic disorders and chromosomal anomalies.
A: EG NIPT PRO is typically recommended from the 10th week of pregnancy onwards. It’s suitable for all pregnant women, especially those at higher risk of chromosomal abnormalities due to factors like advanced maternal age (35 years or older), a family history of genetic conditions, or abnormal results from other prenatal screenings. It’s also a good choice for expectant parents seeking early reassurance about their baby’s genetic health.
A: EG NIPT PRO is very safe because it is non-invasive. The test requires only a blood sample from the mother, posing no risk to the fetus. Unlike invasive procedures such as amniocentesis, which carry a small risk of miscarriage, EG NIPT PRO does not involve such risks, making it a preferred option for initial prenatal screening.
A: While EG NIPT PRO is highly accurate, it is not infallible. It is a screening tool, meaning it assesses the risk of certain genetic conditions but does not provide a definitive diagnosis. There are rare instances of false positives (indicating a high risk of a condition that is not present) and false negatives (missing a condition). For this reason, any high-risk result should be confirmed with further diagnostic testing.
A: In some cases, EG NIPT PRO may not be able to provide a conclusive result. This can happen if there is insufficient fetal DNA in the mother’s blood sample, which is more likely earlier in pregnancy or in cases where the mother has a higher body weight. If EG NIPT PRO cannot make an assessment, please, contact us.
By introducing this state-of-the-art our NIPT service, your organization will position itself as a trailblazer in prenatal genetic screening, both domestically and globally. This service will transform the quality of your healthcare offerings, providing expectant parents with the most comprehensive and precise genetic information available, and setting a new standard in the industry.